HIGHBRIDGE CAPITAL MANAGEMENT

highbridge-capital-management-logo

HCM is a global alternative investment management firm launched in 1992. Since its inception, the company has developed a diversified investment platform that includes hedge funds, traditional investment management products and debt and private equity investments with longer-term holding periods. With over 300 employees, including almost 100 investment professionals, HCM manages approximately $21 billion of capital for some of the world's most prominent institutional investors, public and corporate pension funds, endowments, foundations and family offices.
#People #Financial #More

HIGHBRIDGE CAPITAL MANAGEMENT

Social Links:

facebook

Facebook

linkedin

Linkedin

Industry:
Finance Financial Services Venture Capital

Founded:
1992-01-01

Status:
Active

Contact:
212 287 4000

Email Addresses:
[email protected]

Technology used in webpage:
SPF SSL By Default Google Font API Domain Not Resolving Google Maps Microsoft Azure DNS Cloudflare JS CDN JS Cloudflare DNS Akamai Hosted


Current Employees Featured

scott-kapnick_image

Scott Kapnick
Scott Kapnick Managing Partne & Board Member @ Highbridge Capital Management
Managing Partne & Board Member

scott-kapnick_image

Scott Kapnick
Scott Kapnick Chief Executive Officer of Highbridge Principal Strategies @ Highbridge Capital Management
Chief Executive Officer of Highbridge Principal Strategies

not_available_image

Jonathan Segal
Jonathan Segal Portfolio Manager, Managing Director @ Highbridge Capital Management
Portfolio Manager, Managing Director

Founder


glenn-dubin_image

Glenn Dubin

Investments List

Date Company Article Money raised
2021-12-28 CompoSecure Highbridge Capital Management investment in Post-IPO Equity - CompoSecure 175 M USD
2021-12-22 Urgently Highbridge Capital Management investment in Debt Financing - Urgently 75 M USD
2021-12-08 BigBear.ai Highbridge Capital Management investment in Post-IPO Debt - BigBear.ai 200 M USD
2021-11-04 Lime Highbridge Capital Management investment in Convertible Note - Lime 418 M USD
2021-09-20 Santhera Pharmaceuticals Highbridge Capital Management investment in Post-IPO Debt - Santhera Pharmaceuticals 25 M CHF
2021-09-20 Santhera Pharmaceuticals Highbridge Capital Management investment in Post-IPO Equity - Santhera Pharmaceuticals 20 M CHF
2021-05-24 Quotient Biodiagnostics Highbridge Capital Management investment in Post-IPO Debt - Quotient Biodiagnostics 95 M USD
2021-02-16 Gamida Cell Highbridge Capital Management investment in Post-IPO Debt - Gamida Cell 75 M USD
2020-06-04 Santhera Pharmaceuticals Highbridge Capital Management investment in Post-IPO Debt - Santhera Pharmaceuticals 20 M CHF
2020-03-12 Protalix BioTherapeutics Highbridge Capital Management investment in Post-IPO Equity - Protalix BioTherapeutics 43.7 M USD

More informations about "Highbridge Capital Management" on Search Engine